美聯新材(300586.SZ)擬在華東地區設立子公司
格隆匯 2 月 1日丨美聯新材(300586.SZ)公佈,鑑於公司子公司廣東美聯隔膜有限公司(“隔膜公司”)剛於近日取得動力鋰電池濕法隔膜產業化建設項目相關用地的不動產權證書,該項目基建工作尚未開展,為使該項目獲得更具優勢的生產要素(如蒸汽)並更加貼近產品需求市場,公司擬在華東地區設立子公司,並將前述項目即動力鋰電池濕法隔膜產業化建設項目的實施主體由隔膜公司變更為該擬新設的子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.